Could these antiviral pills treat long COVID?

SAN JOSE, Calif. -- Could Paxlovid solve one of the pandemic’s biggest puzzles? A new study at Stanford University aims to find out. In the nation’s first medical trial of an antiviral strategy to treat long COVID, scientists are testing the drug to see if it helps ease the misery of fatigue, brain fog, shortness of breath, body aches, digestive symptoms and heart problems. “It is important to gain further understanding whether this could be effective therapy,” said principal investigator Dr. Linda Geng, clinical assistant professor at Stanford Medicine and co-director of Stanford’s Post-Acute...